ERBB2 and invasive ductal breast carcinoma: Herein, we try to identify the breast cancer recurrence-related proteins through using the comparative proteomics to analyze the differential proteins between the breast invasive ductal carcinoma with a higher risk of recurrence (LN+ER/PR-Her2+) and those with a lower risk of recurrence (LN-ER/PR+Her2-).